We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.09%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$541B
AUM Growth
+$82.1B
Cap. Flow
+$80.6B
Cap. Flow %
14.9%
Top 10 Hldgs %
15.6%
Holding
10,816
New
1,382
Increased
6,044
Reduced
2,041
Closed
943

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 9.06%
3 Consumer Discretionary 7.01%
4 Healthcare 6.25%
5 Industrials 6.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXR icon
7851
Daxor
DXR
$61.2M
$20K ﹤0.01%
2,599
+1,363
+110% +$12K
CPHC icon
7852
Canterbury Park Holding Corp
CPHC
$79.7M
$20K ﹤0.01%
974
+438
+82% +$8.8K
POLE
7853
Andretti Acquisition Corp II
POLE
$319M
$19.9K ﹤0.01%
+1,995
New +$19.9K
GCAL
7854
Goldman Sachs Dynamic California Municipal Income ETF
GCAL
$172M
$19.9K ﹤0.01%
397
-703
-64% -$35.6K
HLP icon
7855
Hongli Group Inc. Class A Ordinary Shares
HLP
$97.9M
$19.8K ﹤0.01%
15,117
+6,392
+73% +$8.2K
HSDT icon
7856
Solana Company
HSDT
$100M
$19.8K ﹤0.01%
39
+22
+129% +$9.16K
SLGL icon
7857
Sol-Gel Technologies
SLGL
$288M
$19.8K ﹤0.01%
2,126
+1,780
+514% +$11.1K
MMA
7858
Alta Global Group
MMA
$11.1M
$19.8K ﹤0.01%
+14,017
New +$24.8K
BYFC icon
7859
Broadway Financial
BYFC
$98.5M
$19.7K ﹤0.01%
2,883
+2,880
+96,000% +$19.8K
XRTX
7860
XORTX Therapeutics
XRTX
$3.79M
$19.7K ﹤0.01%
3,486
-270
-7% -$1.86K
TFPN icon
7861
Blueprint Chesapeake Multi-Asset Trend ETF
TFPN
$160M
$19.7K ﹤0.01%
794
+562
+242% +$14K
DHDG
7862
FT Vest U.S. Equity Quarterly 2.5 to 15 Buffer ETF
DHDG
$73.1M
$19.7K ﹤0.01%
+644
New +$19.8K
CSM icon
7863
ProShares Large Cap Core Plus
CSM
$532M
$19.6K ﹤0.01%
+297
New +$19.9K
IXHL icon
7864
Incannex Healthcare
IXHL
$36.9M
$19.6K ﹤0.01%
309
+211
+215% +$12.7K
AVRE icon
7865
Avantis Real Estate ETF
AVRE
$877M
$19.6K ﹤0.01%
468
-1,853
-80% -$82.8K
GDC icon
7866
GD Culture Group
GDC
$6.87M
$19.6K ﹤0.01%
42
-113
-73% -$63.6K
APRE icon
7867
Aprea Therapeutics
APRE
$7.69M
$19.5K ﹤0.01%
5,935
+5,932
+197,733% +$19.8K
TULP
7868
Bloomia Holdings
TULP
$16.5M
$19.5K ﹤0.01%
4,013
+3,737
+1,354% +$14.6K
NRES icon
7869
Xtrackers RREEF Global Natural Resources ETF
NRES
$34.7M
$19.5K ﹤0.01%
821
+811
+8,110% +$21K
SOAR icon
7870
Volato Group
SOAR
$7.18M
$19.4K ﹤0.01%
+3,175
New +$21.8K
CPIX icon
7871
Cumberland Pharmaceuticals
CPIX
$113M
$19.4K ﹤0.01%
8,195
-1,476
-15% -$2.17K
BYAH
7872
Park Ha Biological Technology Co
BYAH
$373K
$19.4K ﹤0.01%
+8
New +$16.2K
ZCMD icon
7873
Zhongchao
ZCMD
$7.26M
$19.4K ﹤0.01%
+16
New +$19.4K
ZOOZ
7874
ZOOZ Strategy Ltd
ZOOZ
$42.3M
$19.3K ﹤0.01%
394
+393
+39,300% +$20.7K
QFLR icon
7875
Innovator Nasdaq-100 Managed Floor ETF
QFLR
$535M
$19.3K ﹤0.01%
+660
New +$18.9K

Similar funds

UBS Group's Q4 2024 Portfolio in Review

As of Q4 2024, UBS Group held 10,816 positions worth $541B, up 18% from $459B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $80.6B of net new capital in Q4 2024, opening 1,382 new positions and adding to 6,044 existing holdings. Its largest new stake was Primo Brands: 1,234,826 shares worth $38M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was UnitedHealth, an estimated $561M trimmed.

  • UBS Group's largest Q4 2024 buy was Primo Brands: 1,234,826 shares worth $38M.
  • UBS Group added most to Strategy Inc in Q4 2024, an estimated $1.21B increase.
  • UBS Group's biggest Q4 2024 reduction was UnitedHealth, cutting an estimated $561M.
  • UBS Group fully exited CATALENT, INC. in Q4 2024, selling an estimated $86M.
  • UBS Group's ten largest holdings make up 16% of its $541B portfolio in Q4 2024.
  • UBS Group opened 1,382 new positions and closed 943 in Q4 2024.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $541B.

Based on UBS Group's 13F filing for Q4 2024, filed 14 Feb 2025.